OrthoSpineNews

APRIL 1, 2025

Optimizing the fixation process with Neos Force Control Technology supports real improvements in clinical outcomes and patients’ quality of life. About the Study The clinical study involved 75 patients undergoing thoracolumbar fusion surgery to treat conditions including trauma, spinal stenosis, and degenerative disc disease.

Degenerative Disc Disease 40

Degenerative Disc Disease Clinic Spine Treatment 40

OrthoSpineNews

MAY 13, 2025

May 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. Food and Drug Association (FDA) is requiring at least a greater than 30% improvement in both Oswestry Disability Index (ODI) and Visual Analog Scale (VAS ); ongoing clinical data demonstrates trends greater than 30% improvements in both measures. MELVILLE, N.Y.,

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Clinic Treatment 52

OrthoSpineNews

MARCH 3, 2025

Frank Phillips Joins SST Board of Directors SAN ANTONIO, March 3, 2025 /PRNewswire/ — Spinal Stabilization Technologies, LLC (SST) has announced a significant milestone in its mission to revolutionize spinal care: the enrollment of the first U.S. “This is an exciting time for SST as we expand our clinical research into the U.S.

Degenerative Disc Disease 52

Degenerative Disc Disease Patients Spine Clinic 52

OrthoSpineNews

JANUARY 7, 2025

January 7, 2025, NEW YORK–( BUSINESS WIRE )–Spine BioPharma, Inc., January 7, 2025, NEW YORK–( BUSINESS WIRE )–Spine BioPharma, Inc., 212-583-9700 jgallagher@spinebiopharma.com Media Inquiries: Sasha Damouni Ellis Damouni Group LLC sasha@damounigroup.com

Degenerative Disc Disease 52

Degenerative Disc Disease Spine Prevention Treatment 52

OrthoSpineNews

MAY 14, 2025

May 14, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. BioRestorative, BRTX or the Company) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its business.

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Neck Pain Treatment 52

OrthoSpineNews

MARCH 10, 2025

This prospective, multi-center, multi-specialty clinical trial is the first of its kind to evaluate the safety and efficacy of lumbar interlaminar fusion devices, marking a significant milestone in the advancement of spinal care. CARLSBAD, Calif., CARLSBAD, Calif.,

Degenerative Disc Disease 52

Degenerative Disc Disease Spine Clinic Musculoskeletal 52

OrthoSpineNews

FEBRUARY 10, 2025

10, 2025/PRNewswire/ — Report on how AI is redefining market landscape – The global spinal implants market size is estimated to grow byUSD 3.55 billionfrom 2025-2029, according to Technavio. Market growth 2025-2029 USD 3554.5 NEW YORK,Feb. The market is estimated to grow at a CAGR of almost5.3% JAYON IMPLANTS Pvt.

Degenerative Disc Disease 40

Degenerative Disc Disease Scoliosis Clients Spine 40